Califf, Robert M.

Changing preferences for survival after hospitalization with advanced heart failure

Stevenson, L. W., Hellkamp, A. S., Leier, C. V., Sopko, G., Koelling, T., Warnica, J. W., Abraham, W. T., Kasper, E. K., Rogers, J. G., Califf, R. M., et al. (2008) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementPalliative Care and End-of-Life Issues

Cited by 164

Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn

Moya, M. P., Gow, A. J., Califf, R. M., Goldberg, R. N., & Stamler, J. S. (2002) · The Lancet

Neonatal Respiratory Health ResearchCardiovascular Conditions and Treatments

Cited by 123

Principles From Clinical Trials Relevant to Clinical Practice: Part I

Califf, R. M., & DeMets, D. L. (2002) · Circulation

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 108

Traversing the valley of death: a guide to assessing prospects for translational success

Coller, B. S., & Califf, R. M. (2009) · Science Translational Medicine

Health and Medical Research ImpactsAnimal testing and alternatives

Cited by 99

Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registry

Bernardez-Pereira, S., Lopes, R. D., Carrion, M. J. M., Santucci, E. V., Soares, R. M., de Oliveira Abreu, M., Laranjeira, L. N., Ikeoka, D. T., Zazula, A. D., Moreira, F. R., et al. (2014) · American Heart Journal

Ethics in Clinical ResearchStatistical Methods in Clinical Trials

Cited by 94

The Project Baseline Health Study: a step towards a broader mission to map human health

Arges, K., Assimes, T., Bajaj, V., Balu, S., Bashir, M. R., Beskow, L., Blanco, R., Califf, R., Campbell, P., Carin, L., et al. (2020) · npj Digital Medicine

Health, Environment, Cognitive AgingArtificial Intelligence in Healthcare and Education

Cited by 82

Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)

Murphy, S. A., Cannon, C. P., Wiviott, S. D., de Lemos, J. A., Blazing, M. A., McCabe, C. H., Califf, R. M., & Braunwald, E. (2007) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 82

Digital clinical trials: creating a vision for the future

Steinhubl, S. R., Wolff-Hughes, D. L., Nilsen, W., Iturriaga, E., & Califf, R. M. (2019) · npj Digital Medicine

Mobile Health and mHealth ApplicationsDigital Mental Health Interventions

Cited by 71

Reengineering the national clinical and translational research enterprise: the strategic plan of the national clinical and translational science awards consortium

Reis, S. E., Berglund, L., Bernard, G. R., Califf, R. M., FitzGerald, G. A., & Johnson, P. C. (2010) · Academic Medicine

Health and Medical Research ImpactsInterdisciplinary Research and Collaboration

Cited by 70

A review of dyspnea in acute heart failure syndromes

West, R. L., Hernandez, A. F., O'Connor, C. M., Starling, R. C., & Califf, R. M. (2010) · American Heart Journal

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 67

Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Meadows, T. A., Bhatt, D. L., Hirsch, A. T., Creager, M. A., Califf, R. M., Ohman, E. M., Cannon, C. P., Eagle, K. A., Alberts, M. J., Goto, S., et al. (2009) · American Heart Journal

Peripheral Artery Disease ManagementLipoproteins and Cardiovascular Health

Cited by 50

Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR

Huffman, K. M., Sun, J.-L., Thomas, L., Bales, C. W., Califf, R. M., Yates, T., Davies, M. J., Holman, R. R., McMurray, J. J. V., Bethel, M. A., et al. (2014) · Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and Health

Cited by 45

Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial

de Barros e Silva, P. G. M., Califf, R. M., Sun, J.-L., McMurray, J. J. V., Holman, R., Haffner, S., Thomas, L., & Lopes, R. D. (2014) · International Journal of Cardiology

Chronic Obstructive Pulmonary Disease (COPD) ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 11